{"organizations": [], "uuid": "941df4bd4c74486640b61ce95da476f073eab5c9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-4451/social", "site_section": "https://www.wsj.com/public/page/archive.html", "section_title": "News Article Archive - Wsj.com", "url": "https://www.wsj.com/articles/race-for-a-cure-spurs-biotechs-to-rely-more-on-nonprofit-backers-1521545439", "country": "US", "domain_rank": 387, "title": "Race for a Cure Spurs Biotechs to Rely More on Nonprofit Backers", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.083, "site_type": "news", "published": "2018-03-20T14:30:00.000+02:00", "replies_count": 0, "uuid": "941df4bd4c74486640b61ce95da476f073eab5c9"}, "author": "Brian Gormley", "url": "https://www.wsj.com/articles/race-for-a-cure-spurs-biotechs-to-rely-more-on-nonprofit-backers-1521545439", "ord_in_thread": 0, "title": "Race for a Cure Spurs Biotechs to Rely More on Nonprofit Backers", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "As biotech startups race to find a cure for rare and other diseases, they’re looking beyond venture capitalists for a leg up.\nIncreasingly they turn to philanthropists, private foundations and other nonprofits—not only for capital and expertise, but also for a crucial link to patients facing down these diseases.\nAlthough such groups invest... ", "external_links": [], "published": "2018-03-20T14:30:00.000+02:00", "crawled": "2018-03-21T10:54:20.040+02:00", "highlightTitle": ""}